MGNX — MacroGenics Cashflow Statement
0.000.00%
Last trade - 00:00- $976.57m
- $746.76m
- $58.75m
- 20
- 16
- 90
- 37
Annual cashflow statement for MacroGenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -152 | -130 | -202 | -120 | -9.06 |
| Depreciation | |||||
| Non-Cash Items | 19.6 | 20.4 | 26.8 | 23.7 | 166 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.9 | -14.5 | 20.3 | -2.79 | -245 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -134 | -112 | -144 | -87 | -78.2 |
| Capital Expenditures | -4.29 | -5.91 | -6.2 | -3.62 | -1.76 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -75.1 | -1.88 | -30.4 | 74.3 | -78.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -79.4 | -7.79 | -36.6 | 70.7 | -80.1 |
| Financing Cash Flow Items | — | — | — | — | 149 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 120 | 174 | 123 | 1.66 | 150 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -93.7 | 54.7 | -57.7 | -14.6 | -7.93 |